中银人寿首三个月新造保费录得双位数增长
本地传媒引述中银人寿执行总裁邓子平表示,公司今年首三个月新造保费录得双位数升幅,主要由於公司将更多产品放在网上销售平台,亦受惠於保监局早前放宽部分产品可作遥距销售,不少客户赶在税务年度完结前购买可扣税产品。惟他表示,封关等措施造成的影响料将於第二季浮现,今年余下季度业务表现则视乎疫情进展。
邓子平又指,公司去年第三季度新造保费收入按年大升两倍,第四季亦增长17.2%,表现好於整体市场,市场去年第三季新造保费按年仅升14.6%,第四季则按年跌17.9%。邓子平表示,去年如万用寿险等个别产品销情理想,另可扣税年金亦有助销售。公司非本地客占比仅约11%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.